The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development
Date
2020Journal
Journal of virologyPublisher
American Society for MicrobiologyType
Article
Metadata
Show full item recordKeyword
Coronavirus Disease 2019 (COVID-19)nucleocapsid protein
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086686612&doi=10.1128%2fJVI.00647-20&partnerID=40&md5=e85e28354071ab089f61afadf34c4f53; http://hdl.handle.net/10713/13205ae974a485f413a2113503eed53cd6c53
10.1128/JVI.00647-20
Scopus Count
Collections
Related articles
- The SARS-CoV-2 N Protein Is a Good Component in a Vaccine.
- Authors: Ahlén G, Frelin L, Nikouyan N, Weber F, Höglund U, Larsson O, Westman M, Tuvesson O, Gidlund EK, Cadossi M, Appelberg S, Mirazimi A, Sällberg M, OPENCORONA Consortium.
- Issue date: 2020 Aug 31
- The genetic sequence, origin, and diagnosis of SARS-CoV-2.
- Authors: Wang H, Li X, Li T, Zhang S, Wang L, Wu X, Liu J
- Issue date: 2020 Sep
- Coronaviruses and SARS-COV-2
- Authors: Hasöksüz M, Kiliç S, Saraç F
- Issue date: 2020 Apr 21
- From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
- Authors: Kandeel M, Ibrahim A, Fayez M, Al-Nazawi M
- Issue date: 2020 Jun
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
- Authors: Ahmed SF, Quadeer AA, McKay MR
- Issue date: 2020 Feb 25